Related Experiment Video
Updated: Oct 28, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels Predict Future Cardiovascular Event Risks in
François-Pantaléon Musungayi Kajingulu1, François Bompeka Lepira1, Aliocha Natuhoyila Nkodila2
1Department of Internal Medicine, Division of Nephrology-Dialysis, University of Kinshasa Hospital, Kinshasa, Democratic Republic of the Congo.
Insights
In Black African hemodialysis patients, elevated proprotein convertase subtilisin/kexin type 9 (PCSK9) is linked to dyslipidemia and a higher risk of cardiovascular events, independent of other factors.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Biochemistry
Background:
- Cardiovascular diseases (CVDs) are a primary cause of mortality.
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) is implicated in lipid homeostasis and may serve as a biomarker.
- Understanding PCSK9's role in dyslipidemia and CVD risk is crucial, especially in specific populations.
Purpose of the Study:
- To investigate the association between serum PCSK9 levels, dyslipidemia, and the future risk of cardiovascular events.
- To evaluate PCSK9 as a potential biomarker in Black African patients with chronic kidney disease (CKD G5).
Main Methods:
- A cross-sectional study involving 251 CKD G5 hemodialysis patients in Kinshasa, DRC.
- Serum PCSK9 and lipid profiles (TC, LDL-c, HDL-c, TG) were measured.
- The Framingham predictive instrument was used to assess cardiovascular event risk.
Main Results:
- Higher PCSK9 levels correlated positively with TC, LDL-c, and TG, and negatively with HDL-c.
- PCSK9, smoking, overweight, and atherogenic dyslipidemia were associated with future cardiovascular events.
- Elevated PCSK9 levels independently predicted an increased risk of cardiovascular events in this population.
Conclusions:
- Increased serum PCSK9 is associated with adverse lipid profiles in Black African hemodialysis patients.
- Serum PCSK9 levels are a significant independent predictor of cardiovascular events in this cohort.
- PCSK9 may be a valuable biomarker for assessing cardiovascular risk in CKD patients of African descent.
Context And Objective:
Cardiovascular diseases are the leading cause of mortality in patients. In this context, proprotein convertase subtilisin/kexin type 9 (PCSK9) appears to be the new biomarker identified as interfering in lipid homeostasis. This study aimed to investigate the association between PCSK9, dyslipidemia, and future risk of cardiovascular events in a population of black Africans.
Methods:
A cross-sectional study was conducted between August 2016 and July 2020 in six hemodialysis centers in the city of Kinshasa, Democratic Republic of the Congo. Serum PCSK9 was measured by ELISA; lipid levels of 251 chronic kidney disease grade 5 (CKD G5) hemodialysis patients and the Framingham predictive instrument were used for predicting cardiac events.
Results:
Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), and triglycerides (TG) were significantly increased in the tertile with the highest PCSK9. By contrast, high-density lipoprotein cholesterol (HDL-c) was significantly decreased in the same tertile. A strong positive and significant correlation was found between PCSK9 and TC, TG, and LDL-c. Negative and significant correlation was observed between PCSK9 and HDL-c. The levels of PCSK9, smoking, overweight, and atherogenic dyslipidemia were associated with future risks for cardiovascular events in univariate analysis. After adjustment, all these variables persisted as independent determinants of future risk for cardiovascular events. The probability of having a cardiovascular event in this population was independently associated with PCSK9 levels. Compared to the patients in the lowest PCSK9 tertile, patients with PCSK9 levels in the middle (aOR 5.9, 95% CI 2.06-17.3, P<0.001) and highest tertiles (aOR 8.9, 95% CI 3.02-25.08, P<0.001) presented a greater risk of cardiac event.
Conclusion:
Increased PCSK9 serum levels are associated with higher levels of TC, LDL-c, and TG and lower levels of HDL-c in black African hemodialysis patients. Serum PCSK9 levels in these patients predict increased risk of cardiovascular events, independent of traditional potential confounders.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemodialysis II: Procedure and Complications

